4//SEC Filing
PATRICK GREGORY S 4
Accession 0001104659-20-122611
CIK 0001356576other
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 5:43 PM ET
Size
8.5 KB
Accession
0001104659-20-122611
Insider Transaction Report
Form 4
PATRICK GREGORY S
VP, Chief Financial Officer
Transactions
- Sale
Common Stock
2020-11-05$23.00/sh−5,000$115,000→ 44,463 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2020-11-05−5,000→ 15,000 totalExercise: $12.98Exp: 2026-03-01→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2020-11-05$12.98/sh+5,000$64,900→ 49,463 total
Footnotes (2)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2020.
- [F2]The option vests in four equal annual installments beginning on March 1, 2017.
Documents
Issuer
SUPERNUS PHARMACEUTICALS, INC.
CIK 0001356576
Entity typeother
Related Parties
1- filerCIK 0001219844
Filing Metadata
- Form type
- 4
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 5:43 PM ET
- Size
- 8.5 KB